Statistics for Intellia Therapeutics (id:6414 NTLA)

Valuation metrics

Market cap

1.46B

Enterprise value

849.02M

Trailing P/E (ttm)

-2.64

Forward P/E

-2.60

PEG ratio

-2.60

Price/Sales (ttm)

33.80

Price/Book (mrq)

1.51

Enterprise Value/Revenue

19.70

Enterprise Value/EBITDA

-1.61

Overview

Shares outstanding

101.85M

Float

100.57M

Shares short

16.15M

% Held by insiders

0.01%

% Held by institutions

0.91%

Average volume (10 days)

3.28M

Average volume (90 days)

Price summary

52-Week low

12.82

52-Week high

34.87

52-Week change

-116.99%

Beta

1.81

50-Day moving average

18.12

200-Day moving average

23.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-1,588.96%

Operational effectiveness

Return on assets

-27.81%

Return on equity

-52.23%

Income statement

Revenue (ttm)

0.45

Revenue per share (ttm)

0.45

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-527,523,008.00

Net income to common (ttm)

-522,284,000.00

Diluted EPS (ttm)

-5.45

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

658.11M

Total cash per share (mrq)

6.46

Total debt (mrq)

101.62M

Total Debt/Equity (mrq)

10.56

Current ratio (mrq)

672.70%

Book value per share (mrq)

9.46

Cash flow

Cash flow statement

-356,739,008.00

Levered free cash flow (LFCF)

-184,956,496.00